Explore more publications!
The Georgian Health Digest
Got News to Share?

The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 17, 2025

CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system
December 17, 2025

CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system

Indeterminate GlobeNewswire
Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers
December 17, 2025

Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers

Indeterminate GlobeNewswire
Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025

Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Addition Therapeutics Announces $100 Million in Funding and Significant Progress Advancing Mission to Fulfill Promise of Genomic Medicine for Chronic and Rare Diseases
December 17, 2025

Addition Therapeutics Announces $100 Million in Funding and Significant Progress Advancing Mission to Fulfill Promise of Genomic Medicine for Chronic and Rare Diseases

Indeterminate GlobeNewswire
Secura Bio Announces NCCN® Duvelisib (COPIKTRA®) Update to Clinical Practice Guidelines in Oncology for Cutaneous T-Cell Lymphoma (CTCL), Including Mycosis Fungoides and Sézary Syndrome
December 17, 2025

Secura Bio Announces NCCN® Duvelisib (COPIKTRA®) Update to Clinical Practice Guidelines in Oncology for Cutaneous T-Cell Lymphoma (CTCL), Including Mycosis Fungoides and Sézary Syndrome

Indeterminate GlobeNewswire
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
December 17, 2025

Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference

Indeterminate GlobeNewswire
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer 
December 17, 2025

Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer 

Indeterminate GlobeNewswire
4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease
December 17, 2025

4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease

Indeterminate GlobeNewswire
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025

Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
December 17, 2025

Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease

Indeterminate GlobeNewswire
When Holiday Cheer Turns to Holiday Stress: A Look at the Mind Behind Seasonal Emotions
December 17, 2025

When Holiday Cheer Turns to Holiday Stress: A Look at the Mind Behind Seasonal Emotions

Indeterminate GlobeNewswire
Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress
December 17, 2025

Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress

Indeterminate GlobeNewswire
Traws Pharma Reports Positive Interim Clinical Data with Ratutrelvir Versus PAXLOVID™, Shows Activity in PAXLOVID-Ineligible COVID-19 Patients
December 17, 2025

Traws Pharma Reports Positive Interim Clinical Data with Ratutrelvir Versus PAXLOVID™, Shows Activity in PAXLOVID-Ineligible COVID-19 Patients

Indeterminate GlobeNewswire
PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Use of the MyoRegulator® Neuromodulation Device in ALS For Slowing the Progression of Functional Symptoms
December 17, 2025

PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Use of the MyoRegulator® Neuromodulation Device in ALS For Slowing the Progression of Functional Symptoms

Indeterminate GlobeNewswire
Rakovina Therapeutics Management to Attend Partnering Meetings During JPM Week, January in San Francisco, California
December 17, 2025

Rakovina Therapeutics Management to Attend Partnering Meetings During JPM Week, January in San Francisco, California

Indeterminate GlobeNewswire
Press release: Availability of the Q4 2025 Aide memoire
December 17, 2025

Press release: Availability of the Q4 2025 Aide memoire

Indeterminate GlobeNewswire
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands
December 17, 2025

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

Indeterminate GlobeNewswire
Communiqué de presse : L’efdoralprine alfa de Sanofi obtient la désignation de médicament orphelin dans l’UE pour l’emphysème lié au déficit en alpha-1-antitrypsine
December 17, 2025

Communiqué de presse : L’efdoralprine alfa de Sanofi obtient la désignation de médicament orphelin dans l’UE pour l’emphysème lié au déficit en alpha-1-antitrypsine

Indeterminate GlobeNewswire
Vireo Growth Inc. Enters into Definitive Agreement to Acquire Certain Assets of PharmaCann Inc.
December 17, 2025

Vireo Growth Inc. Enters into Definitive Agreement to Acquire Certain Assets of PharmaCann Inc.

Indeterminate GlobeNewswire
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
December 17, 2025

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions